Clicky

Friday, November 20, 2026
All public companies · Official EDGAR

CRVSCorvus Pharmaceuticals, Inc.

Nasdaq · CIK 0001626971
Filer categoryNon-accelerated filer<br>Smaller reporting company
Entity typeoperating
SIC2834 Pharmaceutical Preparations
FY end1231
XBRL facts320

Identity from submissions API

NameCorvus Pharmaceuticals, Inc.
CIK0001626971
TickersCRVS
ExchangesNasdaq
Entity typeoperating
CategoryNon-accelerated filer<br>Smaller reporting company
SIC2834 Pharmaceutical Preparations
EIN464670809
LEI—
Fiscal year end1231
State of incorporationDE DE
Phone(650) 900-4520
Website—
Investor website—
Owner org03 Life Sciences
Flags—
Description—
Insider transactions (issuer)1
Insider transactions (owner)0

Former names

  • None listed.
Business address
901 GATEWAY BLVD, THIRD FLOOR
SOUTH SAN FRANCISCO
CA
94080
CA
Mailing address
901 GATEWAY BLVD, THIRD FLOOR
SOUTH SAN FRANCISCO
CA
94080
CA

EDGAR has no company-logo API. Website field is shown when the filer provided one.

Financialist coverage

SEC filings

585 filing rows loaded from submissions recent.

FiledFormDocumentItemsAccessionFile no.FilmActSizeXBRLiXBRL
2026-11-13 4 FORM 4 0001610717-26-000454 8698
2026-11-10 SCHEDULE 13G xslSCHEDULE_13G_X02/primary_doc.xml 0000093751-26-000636 005-89443 261537867 34 8063
2026-11-05 10-Q 10-Q 0001104659-26-123317 001-37719 261527186 34 11586284 1 1
2026-11-05 8-K FORM 8-K 2.02,9.01 0001171843-26-007175 001-37719 261527045 34 286961 1 1
2026-08-07 SCHEDULE 13G xslSCHEDULE_13G_X02/primary_doc.xml 0000093751-26-000443 005-89443 261251737 34 8096
2026-08-06 10-Q 10-Q 0001104659-26-091975 001-37719 261248805 34 9712993 1 1
2026-08-06 8-K FORM 8-K 2.02,9.01 0001171843-26-005317 001-37719 261248734 34 281013 1 1
2026-07-27 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0002012383-26-002292 005-89443 261206158 34 11017
2026-07-22 8-K 8-K 5.02 0001104659-26-085790 001-37719 261193712 34 141132 1 1
2026-06-15 4 xslF345X06/form4.xml 0001610717-26-000223 6868
2026-06-15 4 xslF345X06/form4.xml 0001610717-26-000222 5362
2026-06-15 4 xslF345X06/form4.xml 0001610717-26-000221 5447
2026-06-15 4 xslF345X06/form4.xml 0001610717-26-000220 6485
2026-06-15 4 xslF345X06/form4.xml 0001610717-26-000219 5409
2026-06-12 8-K FORM 8-K 5.07 0001171843-26-004094 001-37719 261086417 34 194891 1 1
2026-05-20 4 xslF345X06/form4.xml 0001610717-26-000160 7117
2026-05-15 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0000919574-26-003462 005-89443 26987579 34 11241
2026-05-15 SCHEDULE 13G xslSCHEDULE_13G_X02/primary_doc.xml 0000919574-26-003217 005-89443 26982446 34 16852
2026-05-14 8-K FORM 8-K 7.01,8.01,9.01 0001171843-26-003397 001-37719 26975783 34 2371201 1 1
2026-05-07 S-8 FORM S-8 0001104659-26-057263 333-295655 26954713 33 228236 1 1
2026-05-07 10-Q 10-Q 0001104659-26-057100 001-37719 26953097 34 8113150 1 1
2026-05-07 8-K FORM 8-K 2.02,9.01 0001171843-26-003154 001-37719 26952942 34 275353 1 1
2026-04-27 4 xslF345X06/form4.xml 0001610717-26-000149 5396
2026-04-27 3 xslF345X06/form3.xml 0001610717-26-000148 9688
2026-04-27 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0002012383-26-001739 005-89443 26901115 34 10977
2026-04-24 DEFA14A DEFA14A 0001104659-26-048600 001-37719 26894250 34 454936
2026-04-24 DEF 14A DEF 14A 0001104659-26-048595 001-37719 26894195 34 2291979 1 1
2026-04-23 8-K 8-K 5.02 0001104659-26-047735 001-37719 26889089 34 144562 1 1
2026-03-26 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0000102909-26-001004 005-89443 26799674 34 7175
2026-03-13 8-K FORM 8-K 1.01,9.01 0001104659-26-027390 001-37719 26750229 34 495419 1 1
2026-03-13 424B5 424B5 0001104659-26-027382 333-294272 26750215 33 527632 1 1
2026-03-13 S-3ASR S-3ASR 0001104659-26-027362 333-294272 26750122 33 906690 1 1
2026-03-12 10-K 10-K 0001104659-26-027047 001-37719 26747598 34 12400497 1 1
2026-03-12 8-K FORM 8-K 2.02,9.01 0001171843-26-001526 001-37719 26747527 34 286185 1 1
2026-02-13 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001104659-26-015263 005-89443 26633665 34 10348
2026-02-05 SCHEDULE 13D/A xslSCHEDULE_13D_X01/primary_doc.xml 0001104659-26-010750 005-89443 26601072 34 34007
2026-01-30 4 xslF345X05/ownership.xml 0000947871-26-000079 58618
2026-01-30 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0000102909-26-000049 005-89443 26581859 34 6973
2026-01-27 SCHEDULE 13D/A xslSCHEDULE_13D_X01/primary_doc.xml 0000947871-26-000068 005-89443 26567884 34 25177
2026-01-23 8-K FORM 8-K 8.01,9.01 0001104659-26-005968 001-37719 26553262 34 550263 1 1
2026-01-23 424B5 424B5 0001104659-26-005967 333-281318 26553257 33 1192883
2026-01-21 S-3MEF S-3MEF 0001104659-26-005527 333-292864 26549559 33 205766 1 1
2026-01-20 424B5 424B5 0001104659-26-005113 333-281318 26543609 33 1244678
2026-01-20 8-K FORM 8-K 8.01 0001104659-26-005035 001-37719 26542968 34 192798 1 1
2026-01-20 8-K FORM 8-K 7.01,8.01,9.01 0001104659-26-004795 001-37719 26541122 34 2490953 1 1
2025-12-08 4 xslF345X05/form4.xml 0001610717-25-000412 5400
2025-12-08 4 xslF345X05/form4.xml 0001610717-25-000411 5383
2025-12-08 4 xslF345X05/form4.xml 0001610717-25-000410 5313
2025-12-08 4 xslF345X05/form4.xml 0001610717-25-000409 5279
2025-11-04 10-Q 10-Q 0001104659-25-106259 001-37719 251448854 34 9214979 1 1
2025-11-04 8-K FORM 8-K 2.02,9.01 0001171843-25-006973 001-37719 251448809 34 288279 1 1
2025-10-17 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0002012383-25-002853 005-89443 251401970 34 10760
2025-10-06 4 xslF345X05/form4.xml 0001610717-25-000360 5269
2025-10-06 3 xslF345X02/form3.xml 0001610717-25-000359 10128
2025-10-02 8-K 8-K 5.02 0001104659-25-096103 001-37719 251369880 34 143932 1 1
2025-08-14 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0000919574-25-004851 005-89443 251217047 34 19267
2025-08-07 10-Q 10-Q 0001558370-25-010755 001-37719 251193793 34 8961069 1 1
2025-08-07 8-K FORM 8-K 2.02,9.01 0001171843-25-005180 001-37719 251193753 34 288294 1 1
2025-07-01 4 xslF345X05/ownership.xml 0000947871-25-000636 12887
2025-07-01 4 xslF345X05/ownership.xml 0000947871-25-000635 10961
2025-06-16 4 xslF345X05/form4.xml 0001610717-25-000233 5310
2025-06-16 4 xslF345X05/form4.xml 0001610717-25-000232 5261
2025-06-16 4 xslF345X05/form4.xml 0001610717-25-000231 5310
2025-06-16 4 xslF345X05/form4.xml 0001610717-25-000230 5939
2025-06-13 8-K FORM 8-K 5.07 0001171843-25-003881 001-37719 251046335 34 193338 1 1
2025-06-06 4 xslF345X05/form4.xml 0001610717-25-000174 6622
2025-06-04 8-K FORM 8-K 7.01,8.01,9.01 0001171843-25-003661 001-37719 251021870 34 491128 1 1
2025-05-15 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0000919574-25-003240 005-89443 25952001 34 20090
2025-05-14 SCHEDULE 13D/A xslSCHEDULE_13D_X01/primary_doc.xml 0000947871-25-000511 005-89443 25948134 34 22635
2025-05-09 4 xslF345X05/form4.xml 0001610717-25-000115 7672
2025-05-08 S-8 FORM S-8 0001104659-25-046261 333-287109 25927557 33 104001
2025-05-08 10-Q 10-Q 0001558370-25-006966 001-37719 25925971 34 7952161 1 1
2025-05-08 8-K FORM 8-K 2.02,7.01,8.01,9.01 0001171843-25-002981 001-37719 25925850 34 972185 1 1
2025-05-01 SCHEDULE 13D/A xslSCHEDULE_13D_X01/primary_doc.xml 0000947871-25-000444 005-89443 25905210 34 23493
2025-04-25 DEFA14A DEFA14A 0001558370-25-005557 001-37719 25874048 34 457451
2025-04-25 DEF 14A DEF 14A 0001558370-25-005552 001-37719 25873700 34 2308354 1 1
2025-04-09 4 xslF345X05/form4.xml 0001610717-25-000098 5225
2025-04-09 3 xslF345X02/form3.xml 0001610717-25-000097 10242
2025-04-09 8-K FORM 8-K 5.02 0001171843-25-002110 001-37719 25825478 34 197739 1 1
2025-03-25 10-K 10-K 0001558370-25-003621 001-37719 25768320 34 11665366 1 1
2025-03-25 8-K FORM 8-K 2.02,9.01 0001171843-25-001689 001-37719 25768205 34 315787 1 1
2025-02-14 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0000919574-25-001469 005-89443 25626422 34 20277
2025-02-13 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0000950170-25-019936 005-89443 25620742 34 10396
2025-01-13 8-K 8-K 7.01,8.01,9.01 0001558370-25-000150 001-37719 25524804 34 369908 1 1
2024-12-23 4 xslF345X05/form4.xml 0001610717-24-000553 5301
2024-12-23 4 xslF345X05/form4.xml 0001610717-24-000552 5328
2024-12-23 4 xslF345X05/form4.xml 0001610717-24-000551 5232
2024-12-23 4 xslF345X05/form4.xml 0001610717-24-000550 5333
2024-12-18 8-K 8-K 7.01,8.01,9.01 0001558370-24-016343 001-37719 241557605 34 610623 1 1
2024-11-12 10-Q 10-Q 0001558370-24-015306 001-37719 241447870 34 8379196 1 1
2024-11-12 8-K FORM 8-K 2.02,9.01 0001171843-24-006284 001-37719 241447811 34 290998 1 1
2024-10-23 8-K 8-K 1.01,9.01 0001558370-24-013518 001-37719 241389327 34 422006 1 1
2024-08-15 EFFECT xslEFFECTX01/primary_doc.xml S-3,,2024-08-15 16:00:00 9999999995-24-002546 333-281318 241214038 33 1769
2024-08-13 CORRESP filename1.htm 0001193125-24-199684 7183
2024-08-13 UPLOAD filename1.pdf 0000000000-24-009221 333-281318 40096
2024-08-06 S-3 S-3 0001193125-24-195009 333-281318 241180658 33 1019136
2024-08-06 10-Q 10-Q 0001558370-24-011076 001-37719 241179014 34 8267461 1 1
2024-08-06 8-K FORM 8-K 2.02,9.01 0001171843-24-004479 001-37719 241178963 34 543958 1 1
2024-08-01 SC 13G/A d11436197_13g-a.htm 0000919574-24-004203 005-89443 241168598 34 130771
2024-06-17 4 xslF345X05/form4.xml 0001610717-24-000345 5300
2024-06-17 4 xslF345X05/form4.xml 0001610717-24-000344 5251
2024-06-17 4 xslF345X05/form4.xml 0001610717-24-000342 5300
2024-06-17 4 xslF345X05/form4.xml 0001610717-24-000341 8678
2024-06-17 4 xslF345X05/form4.xml 0001610717-24-000340 8149
2024-06-14 8-K FORM 8-K 5.07 0001171843-24-003444 001-37719 241044972 34 200251 1 1
2024-05-14 4 xslF345X05/form4.xml 0001610717-24-000237 5370
2024-05-13 SC 13G/A d11045799_13g-a.htm 0000919574-24-002861 005-89443 24939917 34 115172
2024-05-09 SC 13G CORVUS PHARMACEUTICALS, INC. 0000902664-24-003432 005-89443 24932071 34 75388
2024-05-08 4 xslF345X05/ownership.xml 0000947871-24-000451 11126
2024-05-08 4 xslF345X05/ownership.xml 0000947871-24-000450 13088
2024-05-08 SC 13D/A AMENDMENT NO. 9 0000947871-24-000449 005-89443 24928063 34 327763
2024-05-07 S-8 S-8 0001558370-24-007094 333-279189 24923276 33 145230
2024-05-07 10-Q 10-Q 0001558370-24-007093 001-37719 24923237 34 6821742 1 1
2024-05-07 4 xslF345X05/form4.xml 0001610717-24-000232 6608
2024-05-07 4 xslF345X05/form4.xml 0001610717-24-000231 7669
2024-05-06 8-K 8-K 1.01,9.01 0001193125-24-131920 001-37719 24917595 34 651264 1 1
2024-05-06 8-K FORM 8-K 2.02,9.01 0001171843-24-002569 001-37719 24917391 34 335669 1 1
2024-05-03 424B5 424B5 0001193125-24-130685 333-270921 24913017 33 579340
2024-05-01 8-K 8-K 8.01,9.01 0001193125-24-127611 001-37719 24903979 34 163078 1 1
2024-04-26 DEFA14A DEFA14A 0001558370-24-005904 001-37719 24883747 34 515298
2024-04-26 DEF 14A DEF 14A 0001558370-24-005898 001-37719 24883530 34 1279838
2024-03-19 10-K 10-K 0001558370-24-003567 001-37719 24762983 34 10676206 1 1
2024-03-19 8-K FORM 8-K 2.02,9.01 0001171843-24-001454 001-37719 24762964 34 557971 1 1
2024-03-01 4 xslF345X05/form4.xml 0001610717-24-000106 5301
2024-02-14 SC 13G d10930307_13g.htm 0000919574-24-001382 005-89443 24635549 34 121386
2024-02-13 SC 13G/A SC 13G/A 0001104659-24-022449 005-89443 24630755 34 66352
2024-02-08 3 xslF345X02/form3.xml 0001610717-24-000049 9499
2024-01-23 8-K FORM 8-K 5.02,8.01,9.01 0001171843-24-000360 001-37719 24553281 34 217037 1 1
2023-12-08 4 xslF345X05/form4.xml 0001610717-23-000395 5250
2023-12-08 4 xslF345X05/form4.xml 0001610717-23-000394 5149
2023-12-08 4 xslF345X05/form4.xml 0001610717-23-000392 5245
2023-12-08 4 xslF345X05/form4.xml 0001610717-23-000391 5090
2023-12-08 4 xslF345X05/form4.xml 0001610717-23-000390 5193
2023-12-08 4 xslF345X05/form4.xml 0001610717-23-000389 5144
2023-12-08 4 xslF345X05/form4.xml 0001610717-23-000388 5193
2023-12-08 4 xslF345X05/form4.xml 0001610717-23-000387 8571
2023-12-08 4 xslF345X05/form4.xml 0001610717-23-000386 8134
2023-11-07 8-K FORM 8-K 2.02,9.01 0001171843-23-006818 001-37719 231383577 34 286514 1 1
2023-11-07 10-Q 10-Q 0001558370-23-017981 001-37719 231383574 34 6902257 1 1
2023-09-07 8-K FORM 8-K 8.01,9.01 0001171843-23-005595 001-37719 231240696 34 230111 1 1
2023-08-08 10-Q 10-Q 0001558370-23-013914 001-37719 231151091 34 7024217 1 1
2023-08-08 8-K FORM 8-K 2.02,9.01 0001171843-23-005102 001-37719 231151048 34 278308 1 1
2023-06-21 8-K FORM 8-K 5.07 0001171843-23-004019 001-37719 231026999 34 203988 1 1
2023-06-20 4 xslF345X04/form4.xml 0001610717-23-000189 8159
2023-06-20 4 xslF345X04/form4.xml 0001610717-23-000188 8596
2023-06-20 4 xslF345X04/form4.xml 0001610717-23-000187 5169
2023-06-20 4 xslF345X04/form4.xml 0001610717-23-000186 5218
2023-06-20 4 xslF345X04/form4.xml 0001610717-23-000185 5218
2023-06-20 4 xslF345X04/form4.xml 0001610717-23-000184 5149
2023-05-16 4 xslF345X04/form4.xml 0001610717-23-000041 4169
2023-05-08 EFFECT xslEFFECTX01/primary_doc.xml S-3,,2023-05-08 16:30:00 9999999995-23-001332 333-270921 23899744 33 1719
2023-05-08 10-Q 10-Q 0001558370-23-008503 001-37719 23897628 34 6152667 1 1
2023-05-08 8-K FORM 8-K 2.02,9.01 0001171843-23-003041 001-37719 23897582 34 277789 1 1
2023-05-04 CORRESP filename1.htm 0001193125-23-135917 7194
2023-04-28 DEFA14A DEFA14A 0001558370-23-007175 001-37719 23860694 34 515539
2023-04-28 DEF 14A DEF 14A 0001558370-23-007172 001-37719 23860671 34 1285216
2023-04-24 8-K FORM 8-K 8.01 0001171843-23-002460 001-37719 23838042 34 195880 1 1
2023-04-03 4 xslF345X04/form4.xml 0001140361-23-015800 5247
2023-04-03 8-K FORM 8-K 5.02 0001171843-23-002089 001-37719 23792715 34 195880 1 1
2023-03-31 UPLOAD filename1.pdf 0000000000-23-003261 40211
2023-03-29 8-K 8-K 1.02 0001193125-23-082785 001-37719 23771618 34 144864 1 1
2023-03-29 S-3 S-3 0001193125-23-082535 333-270921 23771561 33 1136111
2023-03-28 S-8 S-8 0001193125-23-082339 333-270910 23770711 33 78273
2023-03-28 10-K 10-K 0001558370-23-004792 001-37719 23769450 34 9522705 1 1
2023-03-28 8-K FORM 8-K 2.02,9.01 0001171843-23-001948 001-37719 23769443 34 287035 1 1
2023-03-13 8-K FORM 8-K 7.01 0001171843-23-001602 001-37719 23725155 34 196013 1 1
2023-02-14 SC 13G/A AMENDMENT NO. 2 0001214659-23-002394 005-89443 23628408 34 79643
2023-02-13 SC 13G CHI ADVISORS LLC 0001085146-23-001070 005-89443 23616007 34 27739
2023-02-10 SC 13G/A SC 13G/A 0001104659-23-018484 005-89443 23611643 34 66253
2023-01-30 SC 13G/A CRVS_SC13GA2_2023.htm 0001319244-23-000009 005-89443 23567954 34 139539
2022-12-20 4 FORM 4 0001567619-22-021876 4555
2022-12-15 4 FORM 4 0001567619-22-021651 7807
2022-12-15 4 FORM 4 0001567619-22-021650 7686
2022-11-03 8-K/A 8-K/A 5.07 0001171843-22-007083 001-37719 221358202 34 195439 1 1
2022-11-03 8-K FORM 8-K 2.02,9.01 0001171843-22-007074 001-37719 221357941 34 280341 1 1
2022-11-03 10-Q 10-Q 0001558370-22-016233 001-37719 221357918 34 6944021 1 1
2022-10-28 8-K FORM 8-K 3.01 0001171843-22-006866 001-37719 221341860 34 198126 1 1
2022-09-28 4 FORM 4 0001567619-22-017917 6059
2022-09-20 4 FORM 4 0001567619-22-017639 8735
2022-08-15 4 FORM 4 0001567619-22-016299 5469
2022-08-15 4 FORM 4 0001567619-22-016289 8621
2022-08-15 4 FORM 4 0001567619-22-016300 5565
2022-08-15 4 FORM 4 0001567619-22-016297 5466
2022-08-15 4 FORM 4 0001567619-22-016298 5528
2022-08-15 4 FORM 4 0001567619-22-016296 5534
2022-08-15 4 FORM 4 0001567619-22-016294 5535
2022-08-15 4 FORM 4 0001567619-22-016295 5485
2022-08-15 4 FORM 4 0001567619-22-016293 8810
2022-08-15 4 OWNERSHIP DOCUMENT 0001104659-22-091430 9169
2022-08-08 10-Q 10-Q 0001558370-22-012619 001-37719 221144406 34 6945899 1 1
2022-08-08 8-K FORM 8-K 2.02,9.01 0001171843-22-005458 001-37719 221144310 34 276574 1 1
2022-06-28 4 FORM 4 0001567619-22-013465 7154
2022-06-17 4 FORM 4 0001567619-22-013140 5561
2022-06-17 4 FORM 4 0001567619-22-013139 5561
2022-06-17 4 FORM 4 0001567619-22-013131 8794
2022-06-17 4 FORM 4 0001567619-22-013130 8647
2022-06-17 4 FORM 4 0001567619-22-013125 5512
2022-06-17 4 FORM 4 0001567619-22-013123 5492
2022-06-17 8-K FORM 8-K 5.07 0001171843-22-004406 001-37719 221023755 34 210620 1 1
2022-06-06 4 FORM 4 0001567619-22-012396 8728
2022-05-05 S-8 FORM S-8 0001104659-22-056514 333-264718 22897237 33 95220
2022-05-05 10-Q 10-Q 0001558370-22-007374 001-37719 22896372 34 6363283 1 1
2022-05-05 8-K FORM 8-K 2.02,9.01 0001171843-22-003326 001-37719 22896192 34 263249 1 1
2022-04-28 DEFA14A DEFA14A 0001558370-22-006291 001-37719 22866777 34 685098
2022-04-28 DEF 14A DEF 14A 0001558370-22-006272 001-37719 22866493 34 1278786
2022-04-01 4 FORM 4 0001567619-22-007839 6055
2022-03-17 4 FORM 4 0001567619-22-007173 8277
2022-03-17 4 FORM 4 0001567619-22-007172 7634
2022-03-10 10-K 10-K 0001558370-22-003281 001-37719 22729169 34 11263849 1 1
2022-03-10 8-K FORM 8-K 2.02,9.01 0001171843-22-001774 001-37719 22729098 34 277064 1 1
2022-02-14 SC 13G/A SC 13G/A 0001104659-22-022833 005-89443 22632149 34 203894
2022-02-14 SC 13G/A AMENDMENT NO. 1 0001214659-22-002554 005-89443 22631035 34 77912
2022-02-14 SC 13G/A AMENDMENT NO. 6 TO THE SCHEDULE 13G 0000921895-22-000439 005-89443 22623819 34 276847
2022-02-14 SC 13G/A SC 13G/A 0001104659-22-020720 005-89443 22623245 34 77673
2022-01-18 SC 13G/A CRVS_SC13GA1.htm 0001319244-22-000012 005-89443 22535770 34 139530
2021-12-06 SC 13G CRVS_SC13G_Dec21.htm 0001319244-21-000264 005-89443 211473612 34 143099
2021-11-03 SC 13D/A AMENDMENT NO. 8 0000947871-21-001134 005-89443 211374976 34 73594
2021-11-02 8-K FORM 8-K 1.01,9.01 0001104659-21-132583 001-37719 211369161 34 490488 1 1
2021-11-02 424B5 424B5 0001104659-21-132576 333-237040 211369142 33 266120
2021-11-01 10-Q 10-Q 0001558370-21-013913 001-37719 211367278 34 7165580 1 1
2021-11-01 8-K FORM 8-K 2.02,9.01 0001171843-21-007353 001-37719 211367194 34 282462 1 1
2021-10-22 SC 13G CRVS_SC13G.htm 0001319244-21-000256 005-89443 211340973 34 158088
2021-10-05 SC 13G/A corvuspharm13a.htm 0000935836-21-000561 005-89443 211305819 34 46853
2021-10-01 4 FORM 4 0001567619-21-017771 7953
2021-09-30 SC 13G SC 13G 0001104659-21-121222 005-89443 211295125 34 271750
2021-09-23 SC 13G/A corvuspharmaceuticals13ga.htm 0000935836-21-000536 005-89443 211272391 34 47218
2021-09-22 4 xslF345X03/ownership.xml 0000947871-21-001017 8568
2021-09-22 4 xslF345X03/ownership.xml 0000947871-21-001016 6639
2021-09-22 SC 13D/A AMENDMENT NO. 7 0000947871-21-001015 005-89443 211270322 34 73540
2021-09-22 3 FORM 3 0001567619-21-017448 5162
2021-09-22 SC 13G p921213sc13g.htm 0001214659-21-009709 005-89443 211268225 34 85818
2021-09-13 4 FORM 4 0001567619-21-017015 5529
2021-09-13 4 FORM 4 0001567619-21-017014 5470
2021-09-13 4 FORM 4 0001567619-21-017013 5566
2021-09-13 4 FORM 4 0001567619-21-017012 5400
2021-09-13 4 FORM 4 0001567619-21-017011 5330
2021-09-13 4 FORM 4 0001567619-21-017010 8633
2021-09-13 4 FORM 4 0001567619-21-017009 8488
2021-09-13 4 FORM 4 0001567619-21-017008 5400
2021-09-13 4 FORM 4 0001567619-21-017007 5351
2021-09-13 4 OWNERSHIP DOCUMENT 0001104659-21-115070 8993
2021-08-23 4 FORM 4 0001567619-21-016250 6053
2021-08-04 SC 13D/A AMENDMENT NO. 6 0000947871-21-000874 005-89443 211145196 34 72463
2021-08-02 10-Q 10-Q 0001558370-21-009818 001-37719 211136393 34 6653141 1 1
2021-08-02 8-K FORM 8-K 2.02,9.01 0001171843-21-005373 001-37719 211136144 34 281135 1 1
2021-07-15 8-K FORM 8-K 2.02,8.01,9.01 0001171843-21-004922 001-37719 211092787 34 236348 1 1
2021-06-16 4 FORM 4 0001567619-21-012199 5490
2021-06-16 4 FORM 4 0001567619-21-012197 5559
2021-06-16 4 FORM 4 0001567619-21-012195 5510
2021-06-16 4 FORM 4 0001567619-21-012193 5559
2021-06-16 4 FORM 4 0001567619-21-012192 8792
2021-06-16 4 FORM 4 0001567619-21-012191 8656
2021-06-16 4 OWNERSHIP DOCUMENT 0001104659-21-082015 9153
2021-06-16 8-K FORM 8-K 5.07 0001171843-21-004375 001-37719 211021504 34 200594 1 1
2021-05-11 SC 13G corvus13g.htm 0000935836-21-000351 005-89443 21911285 34 47450
2021-05-05 4 FORM 4 0001567619-21-009124 5569
2021-04-29 S-8 FORM S-8 0001104659-21-057644 333-255614 21871095 33 93593
2021-04-29 10-Q 10-Q 0001558370-21-005258 001-37719 21870834 34 6025885 1 1
2021-04-29 8-K FORM 8-K 2.02,9.01 0001171843-21-002948 001-37719 21870562 34 275506 1 1
2021-04-20 DEFA14A DEFA14A 0001558370-21-004520 001-37719 21838641 34 473722
2021-04-20 DEF 14A DEF 14A 0001558370-21-004513 001-37719 21838508 34 991627
2021-03-29 SEC STAFF LETTER filename1.pdf 9999999997-21-000995 274525
2021-03-25 10-K 10-K 0001558370-21-003462 001-37719 21770339 34 11403593 1 1
2021-03-25 8-K FORM 8-K 2.02,9.01 0001171843-21-002056 001-37719 21770179 34 276141 1 1
2021-03-22 8-K FORM 8-K 5.02 0001171843-21-001938 001-37719 21759353 34 195665 1 1
2021-03-01 SEC STAFF LETTER filename1.pdf 9999999997-21-000537 276489
2021-02-19 4 xslF345X03/ownership.xml 0000947871-21-000249 8410
2021-02-19 4 xslF345X03/ownership.xml 0000947871-21-000248 6498
2021-02-17 SC 13D/A AMENDMENT NO. 5 0000947871-21-000229 005-89443 21645960 34 72653
2021-02-17 4 FORM 4 0001567619-21-004271 5002
2021-02-17 8-K FORM 8-K 8.01,9.01 0001104659-21-024824 001-37719 21644876 34 448200 1 1
2021-02-16 SC 13G/A SC 13G/A 0001104659-21-022299 005-89443 21631534 34 76763
2021-02-12 SC 13G/A AMENDMENT NO. 5 TO THE SCHEDULE 13G 0000921895-21-000376 005-89443 21627329 34 285271
2021-02-12 424B5 424B5 0001104659-21-021309 333-237040 21623189 33 1044311
2021-02-11 424B5 424B5 0001104659-21-020808 333-237040 21620915 33 1047559
2021-02-11 8-K FORM 8-K 2.02 0001104659-21-020775 001-37719 21620598 34 199554 1 1
2021-02-04 8-K FORM 8-K 8.01 0001171843-21-000733 001-37719 21588864 34 204322 1 1
2020-12-17 4 FORM 4 0001567619-20-021269 5566
2020-12-17 4 FORM 4 0001567619-20-021268 5470
2020-12-17 4 FORM 4 0001567619-20-021266 5529
2020-12-17 4 FORM 4 0001567619-20-021265 5492
2020-12-17 8-K FORM 8-K 5.02 0001171843-20-008615 001-37719 201396146 34 203127 1 1
2020-12-07 8-K FORM 8-K 8.01 0001171843-20-008399 001-37719 201371374 34 215341 1 1
2020-11-09 8-K FORM 8-K 8.01 0001171843-20-007780 001-37719 201296209 34 326973 1 1
2020-10-29 10-Q 10-Q 0001558370-20-012039 001-37719 201272837 34 7047999 1 1
2020-10-29 8-K FORM 8-K 2.02,9.01 0001171843-20-007397 001-37719 201272593 34 280839 1 1
2020-10-05 8-K FORM 8-K 1.01,2.01,8.01,9.01 0001104659-20-112250 001-37719 201224224 34 703665 1 1
2020-09-17 8-K FORM 8-K 8.01 0001171843-20-006493 001-37719 201180050 34 203615 1 1
2020-09-15 4 FORM 4 0001567619-20-016744 5449
2020-09-15 3 FORM 3 0001567619-20-016741 9674
2020-09-11 8-K FORM 8-K 5.02 0001171843-20-006411 001-37719 201170000 34 207778 1 1
2020-09-10 8-K FORM 8-K 8.01 0001171843-20-006380 001-37719 201167806 34 207130 1 1
2020-07-30 10-Q 10-Q 0001558370-20-008756 001-37719 201061445 34 6312169 1 1
2020-07-30 8-K FORM 8-K 2.02,9.01 0001171843-20-005409 001-37719 201061307 34 284782 1 1
2020-07-09 4 FORM 4 SUBMISSION 0001209191-20-041990 7785
2020-07-09 SC 13D/A AMENDMENT NO. 3 TO SCHEDULE 13D 0001193125-20-190472 005-89443 201020841 34 56955
2020-07-07 8-K FORM 8-K 8.01 0001171843-20-004791 001-37719 201015224 34 844781 1 1
2020-06-15 4 OWNERSHIP DOCUMENT 0001104659-20-073458 9148
2020-06-12 4 FORM 4 0001567619-20-012102 8653
2020-06-12 4 FORM 4 0001567619-20-012101 5558
2020-06-12 4 FORM 4 0001567619-20-012100 5495
2020-06-12 4 FORM 4 0001567619-20-012099 8791
2020-06-12 4 FORM 4 0001567619-20-012098 5529
2020-06-12 4 FORM 4 0001567619-20-012097 5509
2020-06-10 8-K FORM 8-K 5.07 0001171843-20-004286 001-37719 20954809 34 204137 1 1
2020-05-29 8-K FORM 8-K 8.01 0001171843-20-004067 001-37719 20924086 34 207083 1 1
2020-05-06 3 FORM 3 SUBMISSION 0001209191-20-027486 4232
2020-04-30 S-8 S-8 0001104659-20-054482 333-237933 20836197 33 94657
2020-04-30 10-Q 10-Q 0001558370-20-004797 001-37719 20835855 34 5632722 1
2020-04-30 8-K FORM 8-K 2.02,9.01 0001171843-20-003129 001-37719 20835678 34 49039
2020-04-17 SC 13D/A AMENDMENT NO. 4 0000947871-20-000390 005-89443 20799857 34 70123
2020-04-15 DEFA14A DEFA14A 0001558370-20-003923 001-37719 20794000 34 311306
2020-04-15 DEF 14A DEF 14A 0001558370-20-003917 001-37719 20793871 34 1142434
2020-03-23 4 FORM 4 0001567619-20-006910 5369
2020-03-23 4 FORM 4 0001567619-20-006909 5349
2020-03-23 4 FORM 4 0001567619-20-006908 5335
2020-03-23 4 FORM 4 0001567619-20-006907 5398
2020-03-23 4 FORM 4 0001567619-20-006905 8493
2020-03-23 4 FORM 4 0001567619-20-006904 8631
2020-03-23 4 OWNERSHIP DOCUMENT 0001104659-20-037295 8985
2020-03-20 8-K FORM 8-K 5.02 0001171843-20-001878 001-37719 20732956 34 19471
2020-03-20 424B5 424B5 0001104659-20-036930 333-237040 20732860 33 371700
2020-03-19 EFFECT xslEFFECTX01/primary_doc.xml S-3,,2020-03-19 16:00:00 9999999995-20-000598 333-237040 20730089 33 1719
2020-03-17 CORRESP filename1.htm 0001104659-20-034837 11392
2020-03-12 UPLOAD filename1.pdf 0000000000-20-002243 45911
2020-03-09 S-3 S-3 0001104659-20-030827 333-237040 20698816 33 797990
2020-03-09 10-K 10-K 0001558370-20-002232 001-37719 20698037 34 11390528 1
2020-03-05 8-K FORM 8-K 2.02,9.01 0001171843-20-001518 001-37719 20690875 34 63894
2020-02-18 SC 13G/A AMENDMENT NO. 4 TO THE SCHEDULE 13G 0000921895-20-000584 005-89443 20625829 34 286802
2020-02-14 SC 13G/A AMENDMENT NO. 3 TO THE SCHEDULE 13G 0000921895-20-000529 005-89443 20618335 34 295684
2020-02-14 SC 13G/A crvs13gadec19.txt 0000080255-20-001312 005-89443 34 7021
2020-02-13 8-K FORM 8-K 7.01,9.01 0001171843-20-000943 001-37719 20607027 34 23907
2020-02-12 SC 13G/A SC 13G/A 0001193125-20-033205 005-89443 20604113 34 70210
2020-02-03 8-K FORM 8-K 7.01,9.01 0001171843-20-000651 001-37719 20567009 34 22910
2019-12-16 4 FORM 4 0001567619-19-023148 5500
2019-12-16 4 FORM 4 0001567619-19-023147 5491
2019-12-16 4 FORM 4 0001567619-19-023146 5529
2019-12-16 4 FORM 4 0001567619-19-023143 5470
2019-12-16 4 FORM 4 0001567619-19-023140 5566
2019-12-16 4 FORM 4 0001567619-19-023139 5510
2019-12-16 4 FORM 4 0001567619-19-023137 5544
2019-12-16 8-K FORM 8-K 5.02 0001171843-19-008140 001-37719 191287037 34 20436
2019-12-09 8-K FORM 8-K 7.01,9.01 0001171843-19-008006 001-37719 191274261 34 23838
2019-11-14 4 FORM 4 0001567619-19-021570 7253
2019-11-12 8-K 8-K 1.01,3.02,9.01 0001104659-19-062177 001-37719 191206457 34 280617
2019-11-08 8-K FORM 8-K 7.01,8.01,9.01 0001171843-19-007381 001-37719 191204010 34 5923212
2019-10-29 10-Q 10-Q 0001558370-19-009354 001-37719 191177132 34 6517453 1
2019-10-29 8-K FORM 8-K 2.02,9.01 0001171843-19-006916 001-37719 191176407 34 55335
2019-08-08 4 xslF345X03/ownership.xml 0000947871-19-000572 6876
2019-08-08 4 xslF345X03/ownership.xml 0000947871-19-000571 8954
2019-08-08 4 FORM 4 SUBMISSION 0000899243-19-021352 7458
2019-08-07 SC 13G/A AMENDMENT NO. 2 TO THE SCHEDULE 13G 0000921895-19-002114 005-89443 191006247 34 209153
2019-08-01 10-Q 10-Q 0001558370-19-006824 001-37719 19993032 34 6313388 1
2019-08-01 8-K FORM 8-K 2.02,9.01 0001171843-19-005090 001-37719 19992761 34 65923
2019-07-29 SC 13D/A SC 13D/A 0001193125-19-205471 005-89443 19981636 34 59410
2019-07-25 4 FORM 4 SUBMISSION 0001209191-19-043285 9299
2019-07-02 SC 13D/A AMENDMENT NO. 3 0000947871-19-000489 005-89443 19937741 34 135768
2019-07-01 4 xslF345X03/ownership.xml 0000947871-19-000487 10191
2019-07-01 4 xslF345X03/ownership.xml 0000947871-19-000486 12273
2019-06-24 4 OWNERSHIP DOCUMENT 0001144204-19-032055 9145
2019-06-24 4 FORM 4 SUBMISSION 0000899243-19-017924 5511
2019-06-24 4 FORM 4 SUBMISSION 0000899243-19-017919 5574
2019-06-24 4 FORM 4 SUBMISSION 0000899243-19-017918 8855
2019-06-24 4 FORM 4 SUBMISSION 0000899243-19-017917 5545
2019-06-24 4 FORM 4 SUBMISSION 0000899243-19-017914 8734
2019-06-24 4 FORM 4 SUBMISSION 0000899243-19-017913 5525
2019-06-24 8-K FORM 8-K 5.07 0001171843-19-004128 001-37719 19913016 34 20368
2019-06-17 4 FORM 4 SUBMISSION 0000899243-19-017182 7457
2019-06-11 4 FORM 4 0001567619-19-013222 7287
2019-06-10 4 FORM 4 0001567619-19-013152 8463
2019-06-03 8-K FORM 8-K 7.01,8.01,9.01 0001171843-19-003763 001-37719 19872214 34 4328330
2019-05-09 S-8 S-8 0001104659-19-028231 333-231331 19811252 33 145953
2019-05-09 10-Q 10-Q 0001558370-19-004697 001-37719 19810988 34 5729972 1
2019-05-09 8-K FORM 8-K 2.02,9.01 0001171843-19-003207 001-37719 19810436 34 53056
2019-04-24 DEFA14A DEFA14A 0001558370-19-003232 001-37719 19763985 34 325006
2019-04-24 DEF 14A DEF 14A 0001558370-19-003229 001-37719 19763955 34 1208170
2019-03-07 10-K 10-K 0001558370-19-001660 001-37719 19666093 34 10505543 1
2019-03-07 8-K FORM 8-K 2.02,9.01 0001171843-19-001583 001-37719 19666021 34 62256
2019-02-14 SC 13G/A AMENDMENT NO. 1 TO THE SCHEDULE 13G 0000921895-19-000470 005-89443 19607079 34 209468
2019-02-14 SC 13G crvs13gdec18.txt 0000080255-19-002716 005-89443 34 6819
2019-02-13 SC 13G/A filing.txt 0000315066-19-000997 005-89443 19594686 34 8361
2019-02-12 SC 13G/A SC 13G/A 0001193125-19-035923 005-89443 19590912 34 71478
2019-02-06 8-K FORM 8-K 7.01,9.01 0001171843-19-000753 001-37719 19569922 34 22801
2019-01-31 SC 13D/A SC 13D/A 0001193125-19-023789 005-89443 19555180 34 58433
2019-01-30 4 FORM 4 SUBMISSION 0000899243-19-002194 5498
2019-01-30 4 FORM 4 SUBMISSION 0000899243-19-002190 5650
2019-01-30 3 FORM 3 SUBMISSION 0000899243-19-002187 7763
2019-01-30 3 FORM 3 SUBMISSION 0000899243-19-002186 7741
2019-01-28 8-K FORM 8-K 5.02,9.01 0001171843-19-000555 001-37719 19545566 34 28862
2019-01-10 8-K FORM 8-K 7.01,9.01 0001171843-19-000219 001-37719 19519301 34 21890
2019-01-08 8-K FORM 8-K 7.01,9.01 0001171843-19-000179 001-37719 19514713 34 23770
2018-12-31 4 FORM 4 SUBMISSION 0000899243-18-031989 5715
2018-12-27 4 FORM 4 SUBMISSION 0000899243-18-031810 6469
2018-12-26 4 FORM 4 SUBMISSION 0000899243-18-031696 6991
2018-12-14 8-K FORM 8-K 5.02 0001171843-18-008443 001-37719 181235730 34 21099
2018-12-14 4 FORM 4 SUBMISSION 0000899243-18-031061 6396
2018-12-14 4 FORM 4 SUBMISSION 0000899243-18-031059 9528
2018-12-14 4 FORM 4 SUBMISSION 0000899243-18-031058 7433
2018-12-14 4 FORM 4 SUBMISSION 0000899243-18-031057 6790
2018-12-14 4 FORM 4 SUBMISSION 0000899243-18-031055 5568

Latest XBRL company facts

One latest value per concept from companyfacts (320 concepts). Full history stays in the JSON.

TaxonomyTagLabelUnitValueStartEndFYFPFormFiledAccn
dei EntityCommonStockSharesOutstanding Entity Common Stock, Shares Outstanding shares 84.35M 2026-11-05 2026 Q3 10-Q 2026-11-05 0001104659-26-123317
dei EntityPublicFloat Entity Public Float USD 251.90M 2025-06-30 2025 FY 10-K 2026-03-12 0001104659-26-027047
ecd NonPeoNeoAvgCompActuallyPaidAmt NonPeoNeoAvgCompActuallyPaidAmt USD 3.24M 2025-01-01 2025-12-31 DEF 14A 2026-04-24 0001104659-26-048595
ecd NonPeoNeoAvgTotalCompAmt NonPeoNeoAvgTotalCompAmt USD 3.18M 2025-01-01 2025-12-31 DEF 14A 2026-04-24 0001104659-26-048595
ecd PeoActuallyPaidCompAmt PeoActuallyPaidCompAmt USD 7.33M 2025-01-01 2025-12-31 DEF 14A 2026-04-24 0001104659-26-048595
ecd PeoTotalCompAmt PeoTotalCompAmt USD 7.03M 2025-01-01 2025-12-31 DEF 14A 2026-04-24 0001104659-26-048595
ecd TotalShareholderRtnAmt TotalShareholderRtnAmt USD 905.88 2025-01-01 2025-12-31 DEF 14A 2026-04-24 0001104659-26-048595
ffd NetFeeAmt NetFeeAmt USD 6,139.85 2026-05-07 S-8 2026-05-07 0001104659-26-057263
ffd TtlFeeAmt TtlFeeAmt USD 6,139.85 2026-05-07 S-8 2026-05-07 0001104659-26-057263
ffd TtlOfferingAmt TtlOfferingAmt USD 44.46M 2026-05-07 S-8 2026-05-07 0001104659-26-057263
ffd TtlOffsetAmt TtlOffsetAmt USD 0 2026-05-07 S-8 2026-05-07 0001104659-26-057263
us-gaap AccountsPayableCurrent Accounts Payable, Current USD 5.65M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001104659-26-123317
us-gaap AccountsPayableOtherCurrent Accounts Payable, Other, Current USD 1.24M 2025-09-30 2025 Q3 10-Q 2025-11-04 0001104659-25-106259
us-gaap AccountsPayableUnderwritersPromotersAndEmployeesOtherThanSalariesAndWagesCurrent Accounts Payable, Underwriters, Promoters, and Employees, Current USD 2.97M 2025-09-30 2025 Q3 10-Q 2025-11-04 0001104659-25-106259
us-gaap AccountsReceivableNetCurrent Accounts Receivable, after Allowance for Credit Loss, Current USD 5,000 2026-09-30 2026 Q3 10-Q 2026-11-05 0001104659-26-123317
us-gaap AccountsReceivableRelatedPartiesCurrent Accounts Receivable, Related Parties, Current USD 429,000 2023-03-31 2023 Q1 10-Q 2023-05-08 0001558370-23-008503
us-gaap AccretionAmortizationOfDiscountsAndPremiumsInvestments Accretion (Amortization) of Discounts and Premiums, Investments USD -426,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001104659-26-123317
us-gaap AccruedEmployeeBenefitsCurrent Accrued Employee Benefits, Current USD 715,000 2025-09-30 2025 Q3 10-Q 2025-11-04 0001104659-25-106259
us-gaap AccruedLiabilitiesCurrent Accrued Liabilities, Current USD 9.28M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001104659-26-123317
us-gaap AccruedProfessionalFeesCurrent Accrued Professional Fees, Current USD 252,000 2026-09-30 2026 Q3 10-Q 2026-11-05 0001104659-26-123317
us-gaap AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment USD 2.81M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001104659-26-123317
us-gaap AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax AOCI, Debt Securities, Available-for-sale, Adjustment, after Tax USD 74,000 2016-03-31 2016 Q1 10-Q 2016-05-05 0001104659-16-118308
us-gaap AccumulatedOtherComprehensiveIncomeLossNetOfTax Accumulated Other Comprehensive Income (Loss), Net of Tax USD -1.59M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001104659-26-123317
us-gaap AdditionalPaidInCapital Additional Paid in Capital USD 674.19M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001104659-26-123317
us-gaap AdditionalPaidInCapitalCommonStock Additional Paid in Capital, Common Stock USD 472.79M 2025-09-30 2025 Q3 10-Q 2025-11-04 0001104659-25-106259
us-gaap AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue APIC, Share-based Payment Arrangement, Increase for Cost Recognition USD 2.83M 2026-07-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001104659-26-123317
us-gaap AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition APIC, Share-based Payment Arrangement, Option, Increase for Cost Recognition USD 12,000 2019-01-01 2019-12-31 2021 FY 10-K 2022-03-10 0001558370-22-003281
us-gaap AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts Adjustments to Additional Paid in Capital, Stock Issued, Issuance Costs USD 7.41M 2016-01-01 2016-12-31 2016 FY 10-K 2017-03-10 0001047469-17-001459
us-gaap AdjustmentsToAdditionalPaidInCapitalWarrantIssued Adjustments to Additional Paid in Capital, Warrant Issued USD 5.03M 2024-01-01 2024-12-31 2025 FY 10-K 2026-03-12 0001104659-26-027047
us-gaap AllocatedShareBasedCompensationExpense Share-based Payment Arrangement, Expense USD 8.09M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001104659-26-123317
us-gaap AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount shares 14.03M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-12 0001104659-26-027047
us-gaap AreaOfRealEstateProperty Area of Real Estate Property sqft 27,280 2021-09-30 2023 FY 10-K 2024-03-19 0001558370-24-003567
us-gaap Assets Assets USD 223.88M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001104659-26-123317
us-gaap AssetsCurrent Assets, Current USD 206.34M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001104659-26-123317
us-gaap AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax Debt Securities, Available-for-sale, Accumulated Gross Unrealized Gain, before Tax USD 63,000 2025-12-31 2026 Q3 10-Q 2026-11-05 0001104659-26-123317
us-gaap AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax Debt Securities, Available-for-sale, Accumulated Gross Unrealized Loss, before Tax USD 1.31M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001104659-26-123317
us-gaap AvailableForSaleDebtSecuritiesAmortizedCostBasis Debt Securities, Available-for-sale, Amortized Cost USD 62.76M 2025-09-30 2025 Q3 10-Q 2025-11-04 0001104659-25-106259
us-gaap AvailableForSaleSecurities Available-for-sale Securities USD 44.95M 2017-12-31 2017 FY 10-K 2018-03-01 0001047469-18-001209
us-gaap AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainBeforeTax Available-for-sale Securities, Accumulated Gross Unrealized Gain, before Tax USD 1,000 2017-09-30 2017 Q3 10-Q 2017-11-02 0001104659-17-065655
us-gaap AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTax Available-for-sale Securities, Accumulated Gross Unrealized Loss, before Tax USD 41,000 2017-12-31 2017 FY 10-K 2018-03-01 0001047469-18-001209
us-gaap AvailableForSaleSecuritiesAmortizedCost Available-for-sale Securities, Amortized Cost Basis USD 44.99M 2017-12-31 2017 FY 10-K 2018-03-01 0001047469-18-001209
us-gaap AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost Debt Securities, Available-for-Sale, Amortized Cost, Maturity, Allocated and Single Maturity Date, Year One USD 112.86M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001104659-26-123317
us-gaap AvailableForSaleSecuritiesDebtSecurities Debt Securities, Available-for-sale USD 62.82M 2025-09-30 2025 Q3 10-Q 2025-11-04 0001104659-25-106259
us-gaap AvailableForSaleSecuritiesDebtSecuritiesCurrent Debt Securities, Available-for-sale, Current USD 187.93M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001104659-26-123317
us-gaap CapitalExpendituresIncurredButNotYetPaid Capital Expenditures Incurred but Not yet Paid USD 188,000 2026-01-01 2026-06-30 2026 Q2 10-Q 2026-08-06 0001104659-26-091975
us-gaap CashAndCashEquivalentsAtCarryingValue Cash and Cash Equivalents, at Carrying Value USD 15.01M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001104659-26-123317
us-gaap CashAndCashEquivalentsPeriodIncreaseDecrease Cash and Cash Equivalents, Period Increase (Decrease) USD 57.46M 2018-01-01 2018-03-31 2018 Q1 10-Q 2018-05-03 0001104659-18-030262
us-gaap CashCashEquivalentsAndShortTermInvestments Cash, Cash Equivalents, and Short-term Investments USD 202.90M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001104659-26-123317
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents USD 15.01M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001104659-26-123317
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect USD 10.44M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001104659-26-123317
us-gaap ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights Class of Warrant or Right, Number of Securities Called by Warrants or Rights shares 8.93M 2024-06-30 2024 Q2 10-Q 2024-08-06 0001558370-24-011076
us-gaap ClassOfWarrantOrRightOutstanding Class of Warrant or Right, Outstanding shares 17.09M 2024-09-30 2024 Q3 10-Q 2024-11-12 0001558370-24-015306
us-gaap CommonStockCapitalSharesReservedForFutureIssuance Common Stock, Capital Shares Reserved for Future Issuance shares 27.96M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001104659-26-123317
us-gaap CommonStockParOrStatedValuePerShare Common Stock, Par or Stated Value Per Share USD/shares 0 2026-09-30 2026 Q3 10-Q 2026-11-05 0001104659-26-123317
us-gaap CommonStockSharesAuthorized Common Stock, Shares Authorized shares 290.00M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001104659-26-123317
us-gaap CommonStockSharesIssued Common Stock, Shares, Issued shares 84.32M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001104659-26-123317
us-gaap CommonStockSharesOutstanding Common Stock, Shares, Outstanding shares 84.32M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001104659-26-123317
us-gaap CommonStockValue Common Stock, Value, Issued USD 8,000 2026-09-30 2026 Q3 10-Q 2026-11-05 0001104659-26-123317
us-gaap CompensationExpenseExcludingCostOfGoodAndServiceSold Compensation Expense, Excluding Cost of Good and Service Sold USD 3.03M 2026-01-01 2026-03-31 2026 Q1 10-Q 2026-05-07 0001104659-26-057100
us-gaap ComprehensiveIncomeNetOfTax Comprehensive Income (Loss), Net of Tax, Attributable to Parent USD -52.69M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001104659-26-123317
us-gaap ContractualObligation Contractual Obligation USD 3.63M 2017-12-31 2017 FY 10-K 2018-03-01 0001047469-18-001209
us-gaap ContractualObligationDueInFourthAndFifthYear Contractual Obligation, to be Paid, Year Four and Five USD 101,000 2017-12-31 2017 FY 10-K 2018-03-01 0001047469-18-001209
us-gaap ContractualObligationDueInNextTwelveMonths Contractual Obligation, to be Paid, Year One USD 1.14M 2017-12-31 2017 FY 10-K 2018-03-01 0001047469-18-001209
us-gaap ContractualObligationDueInSecondAndThirdYear Contractual Obligation, to be Paid, Year Two and Three USD 2.39M 2017-12-31 2017 FY 10-K 2018-03-01 0001047469-18-001209
us-gaap ConversionOfStockAmountIssued1 Conversion of Stock, Amount Issued USD 1.77M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-12 0001104659-26-027047
us-gaap ConvertiblePreferredStockSharesIssuedUponConversion Convertible Preferred Stock, Shares Issued upon Conversion shares 1 2016-03-29 2017 FY 10-K 2018-03-01 0001047469-18-001209
us-gaap CostsAndExpenses Costs and Expenses USD 14.64M 2018-01-01 2018-03-31 2018 Q1 10-Q 2018-05-03 0001104659-18-030262
us-gaap DebtSecuritiesAvailableForSaleAmortizedCostCurrent Debt Securities, Available-for-sale, Amortized Cost, Current USD 189.24M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001104659-26-123317
us-gaap DeconsolidationGainOrLossAmount Deconsolidation, Gain (Loss), Amount USD 37.46M 2020-01-01 2020-12-31 2021 FY 10-K 2023-03-28 0001558370-23-004792
us-gaap DeferredCompensationSharebasedArrangementsLiabilityClassifiedNoncurrent Deferred Compensation Share-based Arrangements, Liability, Classified, Noncurrent USD 11,000 2017-12-31 2018 FY 10-K 2019-03-07 0001558370-19-001660
us-gaap DeferredOfferingCosts Deferred Offering Costs USD 951,000 2015-12-31 2016 FY 10-K 2017-03-10 0001047469-17-001459
us-gaap DeferredRentCreditCurrent Deferred Rent Credit, Current USD 160,000 2018-12-31 2019 Q3 10-Q 2019-10-29 0001558370-19-009354
us-gaap DeferredRentCreditNoncurrent Deferred Rent Credit, Noncurrent USD 869,000 2018-12-31 2019 FY 10-K 2020-03-09 0001558370-20-002232
us-gaap DeferredTaxAssetsGross Deferred Tax Assets, Gross USD 102.35M 2025-12-31 2025 FY 10-K 2026-03-12 0001104659-26-027047
us-gaap DeferredTaxAssetsInProcessResearchAndDevelopment Deferred Tax Assets, in Process Research and Development USD 7.09M 2025-12-31 2025 FY 10-K 2026-03-12 0001104659-26-027047
us-gaap DeferredTaxAssetsLiabilitiesNet Deferred Tax Assets, Net USD 0 2025-12-31 2025 FY 10-K 2026-03-12 0001104659-26-027047
us-gaap DeferredTaxAssetsNet Deferred Tax Assets, Net of Valuation Allowance USD 0 2022-12-31 2021 FY 10-K 2023-03-28 0001558370-23-004792
us-gaap DeferredTaxAssetsOperatingLossCarryforwards Deferred Tax Assets, Operating Loss Carryforwards USD 75.43M 2025-12-31 2025 FY 10-K 2026-03-12 0001104659-26-027047
us-gaap DeferredTaxAssetsOther Deferred Tax Assets, Other USD 21,000 2022-12-31 2024 FY 10-K 2025-03-25 0001558370-25-003621
us-gaap DeferredTaxAssetsPropertyPlantAndEquipment Deferred Tax Assets, Property, Plant and Equipment USD 80,000 2025-12-31 2025 FY 10-K 2026-03-12 0001104659-26-027047
us-gaap DeferredTaxAssetsTaxCreditCarryforwards Deferred Tax Assets, Tax Credit Carryforwards USD 13.69M 2025-12-31 2025 FY 10-K 2026-03-12 0001104659-26-027047
us-gaap DeferredTaxAssetsTaxCreditCarryforwardsResearch Deferred Tax Assets, Tax Credit Carryforwards, Research USD 4.52M 2022-12-31 2021 FY 10-K 2023-03-28 0001558370-23-004792
us-gaap DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost USD 5.65M 2025-12-31 2025 FY 10-K 2026-03-12 0001104659-26-027047
us-gaap DeferredTaxAssetsTaxDeferredExpenseOther Deferred Tax Assets, Tax Deferred Expense, Other USD 21,000 2022-12-31 2023 FY 10-K 2024-03-19 0001558370-24-003567
us-gaap DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals USD 124,000 2022-12-31 2021 FY 10-K 2023-03-28 0001558370-23-004792
us-gaap DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Accrued Liabilities USD 145,000 2025-12-31 2025 FY 10-K 2026-03-12 0001104659-26-027047
us-gaap DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsDeferredRent Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Deferred Rent USD 262,000 2025-12-31 2025 FY 10-K 2026-03-12 0001104659-26-027047
us-gaap DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsOther Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Other USD 728,000 2022-12-31 2021 FY 10-K 2023-03-28 0001558370-23-004792
us-gaap DeferredTaxAssetsValuationAllowance Deferred Tax Assets, Valuation Allowance USD 102.10M 2025-12-31 2025 FY 10-K 2026-03-12 0001104659-26-027047
us-gaap DeferredTaxLiabilitiesLeasingArrangements Deferred Tax Liabilities, Leasing Arrangements USD 235,000 2025-12-31 2025 FY 10-K 2026-03-12 0001104659-26-027047
us-gaap DeferredTaxLiabilitiesOther Deferred Tax Liabilities, Other USD 14,000 2025-12-31 2025 FY 10-K 2026-03-12 0001104659-26-027047
us-gaap Depreciation Depreciation USD 623,000 2017-01-01 2017-09-30 2017 Q3 10-Q 2017-11-02 0001104659-17-065655
us-gaap DepreciationAndAmortization Depreciation, Depletion and Amortization, Nonproduction USD 158,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001104659-26-123317
us-gaap DepreciationDepletionAndAmortization Depreciation, Depletion and Amortization USD 158,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001104659-26-123317
us-gaap DividendsCommonStock Dividends, Common Stock USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001104659-26-123317
us-gaap EarningsPerShareBasic Earnings Per Share, Basic USD/shares -0.57 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001104659-26-123317
us-gaap EarningsPerShareBasicAndDiluted Earnings Per Share, Basic and Diluted USD/shares -0.84 2021-01-01 2021-09-30 2021 Q3 10-Q 2021-11-01 0001558370-21-013913
us-gaap EarningsPerShareDiluted Earnings Per Share, Diluted USD/shares -0.57 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001104659-26-123317
us-gaap EffectiveIncomeTaxRateContinuingOperations Effective Income Tax Rate Reconciliation, Percent pure 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-12 0001104659-26-027047
us-gaap EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent pure 0.21 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-12 0001104659-26-027047
us-gaap EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent pure -0.58 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-12 0001104659-26-027047
us-gaap EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate Effective Income Tax Rate Reconciliation, Change in Enacted Tax Rate, Percent pure -0.09 2017-01-01 2017-12-31 2019 FY 10-K 2020-03-09 0001558370-20-002232
us-gaap EffectiveIncomeTaxRateReconciliationDeductionsOther Effective Income Tax Rate Reconciliation, Deduction, Other, Percent pure 0.01 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-25 0001558370-25-003621
us-gaap EffectiveIncomeTaxRateReconciliationEquityInEarningsLossesOfUnconsolidatedSubsidiary Effective Income Tax Rate Reconciliation, Equity in Earnings (Losses) of Unconsolidated Subsidiary, Percent pure 0.01 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-25 0001558370-25-003621
us-gaap EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential Effective Income Tax Rate Reconciliation, Foreign Income Tax Rate Differential, Percent pure -0.17 2017-01-01 2017-12-31 2019 FY 10-K 2020-03-09 0001558370-20-002232
us-gaap EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Percent pure 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-12 0001104659-26-027047
us-gaap EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Percent pure -0.05 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-12 0001104659-26-027047
us-gaap EffectiveIncomeTaxRateReconciliationOtherAdjustments Effective Income Tax Rate Reconciliation, Other Adjustments, Percent pure -0.15 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-25 0001558370-25-003621
us-gaap EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent Effective Income Tax Rate Reconciliation,Other Reconciling Items, Percent pure -0.01 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-25 0001558370-25-003621
us-gaap EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes Effective Income Tax Rate Reconciliation, Prior Year Income Taxes, Percent pure -0.01 2021-01-01 2021-12-31 2023 FY 10-K 2024-03-19 0001558370-24-003567
us-gaap EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent Effective Income Tax Rate Reconciliation, Tax Expense (Benefit), Share-based Payment Arrangement, Percent pure -0.01 2023-01-01 2023-12-31 2024 FY 10-K 2025-03-25 0001558370-25-003621
us-gaap EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Percent pure -0.09 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-12 0001104659-26-027047
us-gaap EffectiveIncomeTaxRateReconciliationTaxContingencies Effective Income Tax Rate Reconciliation, Tax Contingency, Percent pure -0.03 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-12 0001104659-26-027047
us-gaap EffectiveIncomeTaxRateReconciliationTaxContingenciesOther Effective Income Tax Rate Reconciliation, Tax Contingency, Other, Percent pure -0.01 2023-01-01 2023-12-31 2025 FY 10-K 2026-03-12 0001104659-26-027047
us-gaap EffectiveIncomeTaxRateReconciliationTaxCreditsResearch Effective Income Tax Rate Reconciliation, Tax Credit, Research, Percent pure -0.06 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-12 0001104659-26-027047
us-gaap EmployeeBenefitsAndShareBasedCompensation Employee Benefits and Share-based Compensation USD 3.76M 2025-01-01 2025-09-30 2025 Q3 10-Q 2025-11-04 0001104659-25-106259
us-gaap EmployeeRelatedLiabilitiesCurrent Employee-related Liabilities, Current USD 1.85M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001104659-26-123317
us-gaap EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount USD 18.60M 2017-12-31 2017 FY 10-K 2018-03-01 0001047469-18-001209
us-gaap EquityMethodInvestments Equity Method Investments USD 14.47M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001104659-26-123317
us-gaap EquitySecuritiesFvNiRealizedGainLoss Equity Securities, FV-NI, Realized Gain (Loss) USD -5.28M 2023-01-01 2023-12-31 2023 FY 10-K 2024-03-19 0001558370-24-003567
us-gaap FairValueAdjustmentOfWarrants Fair Value Adjustment of Warrants USD -27.14M 2025-01-01 2025-09-30 2026 Q3 10-Q 2026-11-05 0001104659-26-123317
us-gaap FairValueAssetsLevel1ToLevel2TransfersAmount Fair Value, Assets, Level 1 to Level 2 Transfers, Amount USD 0 2022-09-30 2022 Q3 10-Q 2022-11-03 0001558370-22-016233
us-gaap FairValueAssetsLevel2ToLevel1TransfersAmount Fair Value, Assets, Level 2 to Level 1 Transfers, Amount USD 0 2022-09-30 2022 Q3 10-Q 2022-11-03 0001558370-22-016233
us-gaap FairValueLiabilitiesLevel1ToLevel2TransfersAmount Fair Value, Liabilities, Level 1 to Level 2 Transfers, Amount USD 0 2022-09-30 2022 Q3 10-Q 2022-11-03 0001558370-22-016233
us-gaap FairValueLiabilitiesLevel2ToLevel1TransfersAmount Fair Value, Liabilities, Level 2 to Level 1 Transfers, Amount USD 0 2022-09-30 2022 Q3 10-Q 2022-11-03 0001558370-22-016233
us-gaap FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersIntoLevel3 Fair Value, Measurement with Unobservable Inputs Reconciliation, Liability, Transfers Into Level 3 USD 0 2022-01-01 2022-09-30 2022 Q3 10-Q 2022-11-03 0001558370-22-016233
us-gaap FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersOutOfLevel3 Fair Value, Measurement with Unobservable Inputs Reconciliation, Liability, Transfers out of Level 3 USD 0 2022-01-01 2022-09-30 2022 Q3 10-Q 2022-11-03 0001558370-22-016233
us-gaap FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3 Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset Transfers Into Level 3 USD 0 2022-01-01 2022-09-30 2022 Q3 10-Q 2022-11-03 0001558370-22-016233
us-gaap FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3 Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Transfers out of Level 3 USD 0 2022-01-01 2022-09-30 2022 Q3 10-Q 2022-11-03 0001558370-22-016233
us-gaap FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Gain (Loss) Included in Earnings USD -17.90M 2015-04-01 2015-06-30 2016 Q1 10-Q 2016-05-05 0001104659-16-118308
us-gaap FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Issuances USD 300,000 2015-01-01 2015-03-31 2016 Q1 10-Q 2016-05-05 0001104659-16-118308
us-gaap FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Settlements USD 20.20M 2015-04-01 2015-06-30 2016 Q1 10-Q 2016-05-05 0001104659-16-118308
us-gaap FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value USD 2.30M 2015-03-31 2016 Q1 10-Q 2016-05-05 0001104659-16-118308
us-gaap FinancialLiabilitiesFairValueDisclosure Financial Liabilities Fair Value Disclosure USD 0 2023-12-31 2024 Q3 10-Q 2024-11-12 0001558370-24-015306
us-gaap GainLossOnSaleOfPropertyPlantEquipment Gain (Loss) on Disposition of Property Plant Equipment USD 5,000 2024-01-01 2024-12-31 2025 FY 10-K 2026-03-12 0001104659-26-027047
us-gaap GeneralAndAdministrativeExpense General and Administrative Expense USD 10.62M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001104659-26-123317
us-gaap GeneralInsuranceExpense General Insurance Expense USD 1.77M 2025-01-01 2025-09-30 2025 Q3 10-Q 2025-11-04 0001104659-25-106259
us-gaap IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic Income (Loss) from Continuing Operations before Income Taxes, Domestic USD -15.28M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-12 0001104659-26-027047
us-gaap IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest USD -41.31M 2022-01-01 2022-12-31 2021 FY 10-K 2023-03-28 0001558370-23-004792
us-gaap IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign Income (Loss) from Continuing Operations before Income Taxes, Foreign USD 157,000 2018-01-01 2018-12-31 2020 FY 10-K 2021-03-25 0001558370-21-003462
us-gaap IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Noncontrolling Interest USD -49.80M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001104659-26-123317
us-gaap IncomeLossFromEquityMethodInvestments Income (Loss) from Equity Method Investments USD -2.20M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001104659-26-123317
us-gaap IncomeTaxesPaidNet Income Taxes Paid, Net USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-12 0001104659-26-027047
us-gaap IncomeTaxExaminationLiabilityRefundAdjustmentFromSettlementWithTaxingAuthority Income Tax Examination, Liability (Refund) Adjustment from Settlement with Taxing Authority USD 0 2024-12-31 2024 FY 10-K 2025-03-25 0001558370-25-003621
us-gaap IncomeTaxExaminationPenaltiesAndInterestAccrued Income Tax Examination, Penalties and Interest Accrued USD 0 2023-12-31 2023 FY 10-K 2024-03-19 0001558370-24-003567
us-gaap IncomeTaxExpenseBenefit Income Tax Expense (Benefit) USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001104659-26-123317
us-gaap IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount USD 8.90M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-12 0001104659-26-027047
us-gaap IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount USD -3.21M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-12 0001104659-26-027047
us-gaap IncomeTaxReconciliationNondeductibleExpenseOther Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Amount USD 61,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-12 0001104659-26-027047
us-gaap IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Amount USD 723,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-12 0001104659-26-027047
us-gaap IncomeTaxReconciliationStateAndLocalIncomeTaxes Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Amount USD 1.31M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-12 0001104659-26-027047
us-gaap IncomeTaxReconciliationTaxContingencies Effective Income Tax Rate Reconciliation, Tax Contingency, Amount USD 453,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-12 0001104659-26-027047
us-gaap IncomeTaxReconciliationTaxCreditsResearch Effective Income Tax Rate Reconciliation, Tax Credit, Research, Amount USD 940,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-12 0001104659-26-027047
us-gaap IncreaseDecreaseInAccountsPayable Increase (Decrease) in Accounts Payable USD 3.15M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001104659-26-123317
us-gaap IncreaseDecreaseInAccountsReceivableRelatedParties Increase (Decrease) in Accounts Receivable, Related Parties USD -43,000 2025-01-01 2025-09-30 2025 Q3 10-Q 2025-11-04 0001104659-25-106259
us-gaap IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities USD 2.79M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001104659-26-123317
us-gaap IncreaseDecreaseInOperatingLeaseLiability IncreaseDecreaseInOperatingLeaseLiability USD -305,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001104659-26-123317
us-gaap IncreaseDecreaseInOtherCurrentAssets Increase (Decrease) in Other Current Assets USD 848,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001104659-26-123317
us-gaap IncreaseDecreaseInOtherNoncurrentAssets Increase (Decrease) in Other Noncurrent Assets USD -276,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001104659-26-123317
us-gaap IncreaseDecreaseInOtherNoncurrentLiabilities Increase (Decrease) in Other Noncurrent Liabilities USD 12,000 2019-01-01 2019-12-31 2019 FY 10-K 2020-03-09 0001558370-20-002232
us-gaap IncreaseDecreaseInOtherOperatingAssets Increase (Decrease) in Other Operating Assets USD 163,000 2024-01-01 2024-09-30 2024 Q3 10-Q 2024-11-12 0001558370-24-015306
us-gaap IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets Increase (Decrease) in Prepaid Expense and Other Assets USD 1.97M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001104659-26-123317
us-gaap IncrementalCommonSharesAttributableToCallOptionsAndWarrants Incremental Common Shares Attributable to Dilutive Effect of Call Options and Warrants shares 1.04M 2025-01-01 2025-09-30 2026 Q3 10-Q 2026-11-05 0001104659-26-123317
us-gaap InterestAndDividendIncomeSecuritiesAvailableForSale Interest and Dividend Income, Securities, Operating, Available-for-sale USD 105,000 2016-01-01 2016-03-31 2016 Q1 10-Q 2016-05-05 0001104659-16-118308
us-gaap InterestReceivable Interest Receivable USD 1.28M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001104659-26-123317
us-gaap InvestmentIncomeInterest Investment Income, Interest USD 343,000 2018-01-01 2018-03-31 2018 Q1 10-Q 2018-05-03 0001104659-18-030262
us-gaap InvestmentIncomeNet Investment Income, Net USD 5.74M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001104659-26-123317
us-gaap LeaseCost Lease, Cost USD 532,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001104659-26-123317
us-gaap LeaseIncentiveReceivableCurrent Lease Incentive Receivable, Current USD 347,000 2015-12-31 2016 FY 10-K 2017-03-10 0001047469-17-001459
us-gaap LesseeOperatingLeaseLiabilityPaymentsDue Lessee, Operating Lease, Liability, to be Paid USD 358,000 2024-09-30 2024 Q3 10-Q 2024-11-12 0001558370-24-015306
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths Lessee, Operating Lease, Liability, to be Paid, Year One USD 1.43M 2023-12-31 2024 Q3 10-Q 2024-11-12 0001558370-24-015306
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearFour Lessee, Operating Lease, Liability, to be Paid, Year Four USD 1.30M 2019-09-30 2019 Q3 10-Q 2019-10-29 0001558370-19-009354
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearThree Lessee, Operating Lease, Liability, to be Paid, Year Three USD 1.43M 2022-09-30 2022 Q3 10-Q 2022-11-03 0001558370-22-016233
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearTwo Lessee, Operating Lease, Liability, to be Paid, Year Two USD 1.39M 2022-09-30 2022 Q3 10-Q 2022-11-03 0001558370-22-016233
us-gaap LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear Lessee, Operating Lease, Liability, to be Paid, Remainder of Fiscal Year USD 358,000 2024-09-30 2024 Q3 10-Q 2024-11-12 0001558370-24-015306
us-gaap LesseeOperatingLeaseLiabilityUndiscountedExcessAmount Lessee, Operating Lease, Liability, Undiscounted Excess Amount USD 280,000 2022-09-30 2022 Q3 10-Q 2022-11-03 0001558370-22-016233
us-gaap Liabilities Liabilities USD 15.56M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001104659-26-123317
us-gaap LiabilitiesAndStockholdersEquity Liabilities and Equity USD 223.88M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001104659-26-123317
us-gaap LiabilitiesCurrent Liabilities, Current USD 15.42M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001104659-26-123317
us-gaap ManufacturingCosts Manufacturing Costs USD 1.83M 2025-01-01 2025-03-31 2025 Q1 10-Q 2025-05-08 0001558370-25-006966
us-gaap NetCashProvidedByUsedInFinancingActivities Net Cash Provided by (Used in) Financing Activities USD 191.72M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001104659-26-123317
us-gaap NetCashProvidedByUsedInFinancingActivitiesContinuingOperations Net Cash Provided by (Used in) Financing Activities, Continuing Operations USD 8,000 2017-01-01 2017-03-31 2017 Q1 10-Q 2017-05-04 0001104659-17-029890
us-gaap NetCashProvidedByUsedInInvestingActivities Net Cash Provided by (Used in) Investing Activities USD -143.29M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001104659-26-123317
us-gaap NetCashProvidedByUsedInInvestingActivitiesContinuingOperations Net Cash Provided by (Used in) Investing Activities, Continuing Operations USD 18.18M 2017-01-01 2017-03-31 2017 Q1 10-Q 2017-05-04 0001104659-17-029890
us-gaap NetCashProvidedByUsedInOperatingActivities Net Cash Provided by (Used in) Operating Activities USD -37.99M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001104659-26-123317
us-gaap NetCashProvidedByUsedInOperatingActivitiesContinuingOperations Net Cash Provided by (Used in) Operating Activities, Continuing Operations USD -12.75M 2017-01-01 2017-03-31 2017 Q1 10-Q 2017-05-04 0001104659-17-029890
us-gaap NetIncomeLoss Net Income (Loss) Attributable to Parent USD -51.99M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001104659-26-123317
us-gaap NetIncomeLossAvailableToCommonStockholdersBasic Net Income (Loss) Available to Common Stockholders, Basic USD -51.99M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001104659-26-123317
us-gaap NetIncomeLossAvailableToCommonStockholdersDiluted Net Income (Loss) Available to Common Stockholders, Diluted USD -51.99M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001104659-26-123317
us-gaap NonoperatingIncomeExpense Nonoperating Income (Expense) USD 1.19M 2026-01-01 2026-03-31 2026 Q1 10-Q 2026-05-07 0001104659-26-057100
us-gaap NumberOfOperatingSegments Number of Operating Segments pure 1 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001104659-26-123317
us-gaap NumberOfReportableSegments Number of Reportable Segments pure 1 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001104659-26-123317
us-gaap OperatingExpenses Operating Expenses USD 55.54M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001104659-26-123317
us-gaap OperatingIncomeLoss Operating Income (Loss) USD -55.54M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001104659-26-123317
us-gaap OperatingLeaseCost Operating Lease, Cost USD 1.22M 2023-01-01 2023-12-31 2023 FY 10-K 2024-03-19 0001558370-24-003567
us-gaap OperatingLeaseLiability Operating Lease, Liability USD 354,000 2024-09-30 2024 Q3 10-Q 2024-11-12 0001558370-24-015306
us-gaap OperatingLeaseLiabilityCurrent Operating Lease, Liability, Current USD 493,000 2026-09-30 2026 Q3 10-Q 2026-11-05 0001104659-26-123317
us-gaap OperatingLeaseLiabilityNoncurrent Operating Lease, Liability, Noncurrent USD 139,000 2026-09-30 2026 Q3 10-Q 2026-11-05 0001104659-26-123317
us-gaap OperatingLeasePayments Operating Lease, Payments USD 562,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001104659-26-123317
us-gaap OperatingLeaseRightOfUseAsset Operating Lease, Right-of-Use Asset USD 563,000 2026-09-30 2026 Q3 10-Q 2026-11-05 0001104659-26-123317
us-gaap OperatingLeasesFutureMinimumPaymentsDue Operating Leases, Future Minimum Payments Due USD 4.91M 2018-12-31 2019 FY 10-K 2020-03-09 0001558370-20-002232
us-gaap OperatingLeasesFutureMinimumPaymentsDueCurrent Operating Leases, Future Minimum Payments Due, Next Twelve Months USD 1.11M 2018-12-31 2019 FY 10-K 2020-03-09 0001558370-20-002232
us-gaap OperatingLeasesFutureMinimumPaymentsDueInFiveYears Operating Leases, Future Minimum Payments, Due in Five Years USD 109,000 2018-12-31 2019 FY 10-K 2020-03-09 0001558370-20-002232
us-gaap OperatingLeasesFutureMinimumPaymentsDueInFourAndFiveYears Operating Leases, Future Minimum Payments, Due in Four and Five Years USD 101,000 2017-12-31 2017 FY 10-K 2018-03-01 0001047469-18-001209
us-gaap OperatingLeasesFutureMinimumPaymentsDueInFourYears Operating Leases, Future Minimum Payments, Due in Four Years USD 1.30M 2018-12-31 2019 FY 10-K 2020-03-09 0001558370-20-002232
us-gaap OperatingLeasesFutureMinimumPaymentsDueInThreeYears Operating Leases, Future Minimum Payments, Due in Three Years USD 1.25M 2018-12-31 2019 FY 10-K 2020-03-09 0001558370-20-002232
us-gaap OperatingLeasesFutureMinimumPaymentsDueInTwoAndThreeYears Operating Leases, Future Minimum Payments, Due in Two and Three Years USD 2.39M 2017-12-31 2017 FY 10-K 2018-03-01 0001047469-18-001209
us-gaap OperatingLeasesFutureMinimumPaymentsDueInTwoYears Operating Leases, Future Minimum Payments, Due in Two Years USD 1.14M 2018-12-31 2019 FY 10-K 2020-03-09 0001558370-20-002232
us-gaap OperatingLeasesFutureMinimumPaymentsDueThereafter Operating Leases, Future Minimum Payments, Due Thereafter USD 95,000 2016-09-30 2016 Q3 10-Q 2016-11-03 0001104659-16-154578
us-gaap OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear Operating Leases, Future Minimum Payments, Remainder of Fiscal Year USD 270,000 2018-09-30 2018 Q3 10-Q 2018-11-01 0001558370-18-008268
us-gaap OperatingLeasesRentExpenseNet Operating Leases, Rent Expense, Net USD 748,000 2018-01-01 2018-12-31 2018 FY 10-K 2019-03-07 0001558370-19-001660
us-gaap OperatingLeaseWeightedAverageDiscountRatePercent Operating Lease, Weighted Average Discount Rate, Percent pure 0.117 2026-09-30 2026 Q3 10-Q 2026-11-05 0001104659-26-123317
us-gaap OtherAccruedLiabilitiesCurrent Other Accrued Liabilities, Current USD 367,000 2026-09-30 2026 Q3 10-Q 2026-11-05 0001104659-26-123317
us-gaap OtherAssetsCurrent Other Assets, Current USD 317,000 2026-09-30 2026 Q3 10-Q 2026-11-05 0001104659-26-123317
us-gaap OtherAssetsNoncurrent Other Assets, Noncurrent USD 1.70M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001104659-26-123317
us-gaap OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeReclassificationAdjustmentsNetOfTax OCI, Debt Securities, Available-for-Sale, Gain (Loss), before Adjustment, after Tax USD -548,000 2026-07-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001104659-26-123317
us-gaap OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax OCI, Debt Securities, Available-for-Sale, Gain (Loss), after Adjustment and Tax USD -1.37M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001104659-26-123317
us-gaap OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax USD 674,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001104659-26-123317
us-gaap OtherComprehensiveIncomeLossNetOfTax Other Comprehensive Income (Loss), Net of Tax USD 86,000 2016-01-01 2016-09-30 2016 Q3 10-Q 2016-11-03 0001104659-16-154578
us-gaap OtherGeneralAndAdministrativeExpense Other General and Administrative Expense USD 1.24M 2026-01-01 2026-03-31 2026 Q1 10-Q 2026-05-07 0001104659-26-057100
us-gaap OtherGeneralExpense Other General Expense USD 1.92M 2026-01-01 2026-03-31 2026 Q1 10-Q 2026-05-07 0001104659-26-057100
us-gaap OtherLiabilitiesNoncurrent Other Liabilities, Noncurrent USD 869,000 2018-12-31 2019 FY 10-K 2020-03-09 0001558370-20-002232
us-gaap OtherNoncashIncomeExpense Other Noncash Income (Expense) USD -47,000 2019-01-01 2019-09-30 2019 Q3 10-Q 2019-10-29 0001558370-19-009354
us-gaap OtherPrepaidExpenseCurrent Other Prepaid Expense, Current USD 1.47M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001104659-26-123317
us-gaap OtherResearchAndDevelopmentExpense Other Research and Development Expense USD 5.04M 2026-01-01 2026-03-31 2026 Q1 10-Q 2026-05-07 0001104659-26-057100
us-gaap PaymentsOfDividendsCommonStock Payments of Ordinary Dividends, Common Stock USD 0 2025-01-01 2025-12-31 DEF 14A 2026-04-24 0001104659-26-048595
us-gaap PaymentsOfStockIssuanceCosts Payments of Stock Issuance Costs USD 729,000 2015-01-01 2015-12-31 2017 FY 10-K 2018-03-01 0001047469-18-001209
us-gaap PaymentsToAcquireAvailableForSaleSecurities Payments to Acquire Available-for-sale Securities USD 88.31M 2017-01-01 2017-12-31 2017 FY 10-K 2018-03-01 0001047469-18-001209
us-gaap PaymentsToAcquireAvailableForSaleSecuritiesDebt Payments to Acquire Debt Securities, Available-for-sale USD 239.86M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001104659-26-123317
us-gaap PaymentsToAcquireEquityMethodInvestments Payments to Acquire Equity Method Investments USD 5.00M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001104659-26-123317
us-gaap PaymentsToAcquirePropertyPlantAndEquipment Payments to Acquire Property, Plant, and Equipment USD 739,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001104659-26-123317
us-gaap PreferredStockParOrStatedValuePerShare Preferred Stock, Par or Stated Value Per Share USD/shares 0 2026-09-30 2026 Q3 10-Q 2026-11-05 0001104659-26-123317
us-gaap PreferredStockSharesAuthorized Preferred Stock, Shares Authorized shares 10.00M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001104659-26-123317
us-gaap PreferredStockSharesIssued Preferred Stock, Shares Issued shares 0 2026-09-30 2026 Q3 10-Q 2026-11-05 0001104659-26-123317
us-gaap PreferredStockSharesOutstanding Preferred Stock, Shares Outstanding shares 0 2026-09-30 2026 Q3 10-Q 2026-11-05 0001104659-26-123317
us-gaap PreferredStockValue Preferred Stock, Value, Issued USD 0 2024-12-31 2024 FY 10-K 2025-03-25 0001558370-25-003621
us-gaap PrepaidExpenseAndOtherAssetsCurrent Prepaid Expense and Other Assets, Current USD 3.39M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001104659-26-123317
us-gaap PrepaidInsurance Prepaid Insurance USD 326,000 2026-09-30 2026 Q3 10-Q 2026-11-05 0001104659-26-123317
us-gaap PrepaidRent Prepaid Rent USD 34,000 2026-03-31 2026 Q1 10-Q 2026-05-07 0001104659-26-057100
us-gaap ProceedsFromDerivativeInstrumentFinancingActivities Proceeds from Derivative Instrument, Financing Activities USD 5.03M 2024-01-01 2024-09-30 2025 Q3 10-Q 2025-11-04 0001104659-25-106259
us-gaap ProceedsFromIssuanceInitialPublicOffering Proceeds from Issuance Initial Public Offering USD 63.70M 2016-03-29 2016 Q1 10-Q 2016-05-05 0001104659-16-118308
us-gaap ProceedsFromIssuanceOfCommonStock Proceeds from Issuance of Common Stock USD 189.41M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001104659-26-123317
us-gaap ProceedsFromIssuanceOfConvertiblePreferredStock Proceeds from Issuance of Convertible Preferred Stock USD 95.57M 2015-01-01 2015-12-31 2017 FY 10-K 2018-03-01 0001047469-18-001209
us-gaap ProceedsFromIssuanceOfWarrants Proceeds from Issuance of Warrants USD 8.93M 2024-01-01 2024-12-31 2025 FY 10-K 2026-03-12 0001104659-26-027047
us-gaap ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities Proceeds from Maturities, Prepayments and Calls of Debt Securities, Available-for-sale USD 102.30M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001104659-26-123317
us-gaap ProceedsFromOtherEquity Proceeds from Other Equity USD 7.84M 2023-01-01 2023-12-31 2025 FY 10-K 2026-03-12 0001104659-26-027047
us-gaap ProceedsFromRepurchaseOfEquity Proceeds from (Repurchase of) Equity USD 71.35M 2016-01-01 2016-12-31 2016 FY 10-K 2017-03-10 0001047469-17-001459
us-gaap ProceedsFromSaleOfAvailableForSaleSecurities Proceeds from Sale of Available-for-sale Securities USD 4.20M 2016-01-01 2016-12-31 2017 FY 10-K 2018-03-01 0001047469-18-001209
us-gaap ProceedsFromSaleOfAvailableForSaleSecuritiesDebt Proceeds from Sale of Debt Securities, Available-for-sale USD 1.01M 2020-01-01 2020-12-31 2021 FY 10-K 2023-03-28 0001558370-23-004792
us-gaap ProceedsFromSaleOfPropertyPlantAndEquipment Proceeds from Sale of Property, Plant, and Equipment USD 5,000 2024-01-01 2024-12-31 2025 FY 10-K 2026-03-12 0001104659-26-027047
us-gaap ProceedsFromStockOptionsExercised Proceeds from Stock Options Exercised USD 2.31M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001104659-26-123317
us-gaap ProceedsFromWarrantExercises Proceeds from Warrant Exercises USD 35.74M 2025-01-01 2025-09-30 2026 Q3 10-Q 2026-11-05 0001104659-26-123317
us-gaap ProfitLoss Net Income (Loss), Including Portion Attributable to Noncontrolling Interest USD -51.99M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001104659-26-123317
us-gaap ProFormaWeightedAverageSharesOutstandingDiluted Pro Forma Weighted Average Shares Outstanding, Diluted shares 27.51M 2018-01-01 2018-12-31 2018 FY 10-K 2019-03-07 0001558370-19-001660
us-gaap PropertyPlantAndEquipmentGross Property, Plant and Equipment, Gross USD 3.61M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001104659-26-123317
us-gaap PropertyPlantAndEquipmentNet Property, Plant and Equipment, Net USD 801,000 2026-09-30 2026 Q3 10-Q 2026-11-05 0001104659-26-123317
us-gaap PurchaseObligationDueInNextTwelveMonths Purchase Obligation, to be Paid, Year One USD 6.20M 2022-06-30 2022 Q2 10-Q 2022-08-08 0001558370-22-012619
us-gaap RentalIncomeNonoperating Rental Income, Nonoperating USD 78,000 2023-01-01 2023-12-31 2024 FY 10-K 2025-03-25 0001558370-25-003621
us-gaap ResearchAndDevelopmentArrangementContractToPerformForOthersCostsIncurredGross Research and Development Arrangement, Contract to Perform for Others, Costs Incurred, Gross USD 25,000 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-25 0001558370-25-003621
us-gaap ResearchAndDevelopmentExpense Research and Development Expense USD 44.92M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001104659-26-123317
us-gaap RetainedEarningsAccumulatedDeficit Retained Earnings (Accumulated Deficit) USD -464.29M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001104659-26-123317
us-gaap RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability Right-of-Use Asset Obtained in Exchange for Operating Lease Liability USD 1.21M 2024-01-01 2024-12-31 2025 FY 10-K 2026-03-12 0001104659-26-027047
us-gaap SecurityDeposit Security Deposit USD 100,000 2015-08-31 2024 Q3 10-Q 2024-11-12 0001558370-24-015306
us-gaap ShareBasedCompensation Share-based Payment Arrangement, Noncash Expense USD 8.09M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001104659-26-123317
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number shares 400,000 2024-09-30 2024 Q3 10-Q 2024-11-12 0001558370-24-015306
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate pure 0 2017-01-01 2017-12-31 2017 FY 10-K 2018-03-01 0001047469-18-001209
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate pure 0.914 2017-01-01 2017-12-31 2017 FY 10-K 2018-03-01 0001047469-18-001209
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Maximum pure 0.847 2015-01-01 2015-12-31 2017 FY 10-K 2018-03-01 0001047469-18-001209
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Minimum pure 0.82 2015-01-01 2015-12-31 2017 FY 10-K 2018-03-01 0001047469-18-001209
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate pure 0.021 2017-01-01 2017-12-31 2017 FY 10-K 2018-03-01 0001047469-18-001209
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Maximum pure 0.022 2015-01-01 2015-12-31 2017 FY 10-K 2018-03-01 0001047469-18-001209
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Minimum pure 0.018 2015-01-01 2015-12-31 2017 FY 10-K 2018-03-01 0001047469-18-001209
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized Share-based Compensation Arrangement by Share-based Payment Award, Number of Additional Shares Authorized shares 840,000 2018-01-01 2018-09-30 2018 Q3 10-Q 2018-11-01 0001558370-18-008268
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant shares 4.88M 2024-09-30 2024 Q3 10-Q 2024-11-12 0001558370-24-015306
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value USD 100,000 2023-01-01 2023-12-31 2023 FY 10-K 2024-03-19 0001558370-24-003567
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period shares 463,960 2018-01-01 2018-09-30 2018 Q3 10-Q 2018-11-01 0001558370-18-008268
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross shares 388,500 2018-01-01 2018-09-30 2018 Q3 10-Q 2018-11-01 0001558370-18-008268
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value USD/shares 1.12 2023-01-01 2023-12-31 2023 FY 10-K 2024-03-19 0001558370-24-003567
us-gaap SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue Share-based Compensation Arrangement by Share-based Payment Award, Option, Nonvested, Weighted Average Exercise Price USD/shares 6.8 2021-12-31 2021 FY 10-K 2022-03-10 0001558370-22-003281
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number shares 9.91M 2024-09-30 2024 Q3 10-Q 2024-11-12 0001558370-24-015306
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price USD/shares 11.95 2018-09-30 2018 Q3 10-Q 2018-11-01 0001558370-18-008268
us-gaap SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1 Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested in Period, Fair Value USD 2.10M 2023-01-01 2023-12-31 2023 FY 10-K 2024-03-19 0001558370-24-003567
us-gaap SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested, Weighted Average Grant Date Fair Value USD/shares 9.09 2021-01-01 2021-12-31 2021 FY 10-K 2022-03-10 0001558370-22-003281
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price USD/shares 1.68 2018-01-01 2018-09-30 2018 Q3 10-Q 2018-11-01 0001558370-18-008268
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price USD/shares 12.68 2018-01-01 2018-09-30 2018 Q3 10-Q 2018-11-01 0001558370-18-008268
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price USD/shares 10.92 2018-01-01 2018-09-30 2018 Q3 10-Q 2018-11-01 0001558370-18-008268
us-gaap ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions Share-based Payment Arrangement, Option, Exercise Price Range, Shares Outstanding shares 6.35M 2021-12-31 2021 FY 10-K 2022-03-10 0001558370-22-003281
us-gaap SharePrice Share Price USD/shares 7.7 2025-12-31 DEF 14A 2026-04-24 0001104659-26-048595
us-gaap StockholdersEquity Stockholders' Equity Attributable to Parent USD 208.32M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001104659-26-123317
us-gaap StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities Stock Issued During Period, Shares, Conversion of Convertible Securities shares 14.27M 2016-03-29 2017 FY 10-K 2018-03-01 0001047469-18-001209
us-gaap StockIssuedDuringPeriodSharesNewIssues Stock Issued During Period, Shares, New Issues shares 1.46M 2021-09-01 2021-09-30 2023 FY 10-K 2024-03-19 0001558370-24-003567
us-gaap StockIssuedDuringPeriodSharesStockOptionsExercised Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period shares 123,189 2018-01-01 2018-09-30 2018 Q3 10-Q 2018-11-01 0001558370-18-008268
us-gaap StockIssuedDuringPeriodValueConversionOfConvertibleSecurities Stock Issued During Period, Value, Conversion of Convertible Securities USD 23.05M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-12 0001104659-26-027047
us-gaap StockIssuedDuringPeriodValueIssuedForServices Stock Issued During Period, Value, Issued for Services USD 327,000 2023-07-01 2023-09-30 2024 Q3 10-Q 2024-11-12 0001558370-24-015306
us-gaap StockIssuedDuringPeriodValueNewIssues Stock Issued During Period, Value, New Issues USD 16.41M 2024-04-01 2024-06-30 2025 Q3 10-Q 2025-11-04 0001104659-25-106259
us-gaap StockIssuedDuringPeriodValueOther Stock Issued During Period, Value, Other USD 7.84M 2023-01-01 2023-12-31 2024 FY 10-K 2025-03-25 0001558370-25-003621
us-gaap StockIssuedDuringPeriodValueStockOptionsExercised Stock Issued During Period, Value, Stock Options Exercised USD 805,000 2026-07-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001104659-26-123317
us-gaap TemporaryEquityCarryingAmountAttributableToParent Temporary Equity, Carrying Amount, Attributable to Parent USD 125.78M 2015-12-31 2016 FY 10-K 2017-03-10 0001047469-17-001459
us-gaap TemporaryEquityLiquidationPreference Temporary Equity, Liquidation Preference USD 108.50M 2015-12-31 2016 FY 10-K 2017-03-10 0001047469-17-001459
us-gaap TemporaryEquityParOrStatedValuePerShare Temporary Equity, Par or Stated Value Per Share USD/shares 0 2016-12-31 2016 FY 10-K 2017-03-10 0001047469-17-001459
us-gaap TemporaryEquitySharesAuthorized Temporary Equity, Shares Authorized shares 14.27M 2015-12-31 2017 FY 10-K 2018-03-01 0001047469-18-001209
us-gaap TemporaryEquitySharesIssued Temporary Equity, Shares Issued shares 0 2016-12-31 2016 FY 10-K 2017-03-10 0001047469-17-001459
us-gaap TemporaryEquitySharesOutstanding Temporary Equity, Shares Outstanding shares 0 2016-12-31 2017 FY 10-K 2018-03-01 0001047469-18-001209
us-gaap UndistributedEarningsOfForeignSubsidiaries Undistributed Earnings of Foreign Subsidiaries USD 11.00M 2025-12-31 2025 FY 10-K 2026-03-12 0001104659-26-027047
us-gaap UnrecognizedTaxBenefits Unrecognized Tax Benefits USD 13.50M 2025-12-31 2025 FY 10-K 2026-03-12 0001104659-26-027047
us-gaap UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions Unrecognized Tax Benefits, Decrease Resulting from Prior Period Tax Positions USD 101,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-12 0001104659-26-027047
us-gaap UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued Unrecognized Tax Benefits, Income Tax Penalties and Interest Accrued USD 0 2025-12-31 2025 FY 10-K 2026-03-12 0001104659-26-027047
us-gaap UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions Unrecognized Tax Benefits, Increase Resulting from Current Period Tax Positions USD 468,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-12 0001104659-26-027047
us-gaap UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions Unrecognized Tax Benefits, Increase Resulting from Prior Period Tax Positions USD 17,000 2024-01-01 2024-12-31 2025 FY 10-K 2026-03-12 0001104659-26-027047
us-gaap UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate Unrecognized Tax Benefits that Would Impact Effective Tax Rate USD 0 2025-12-31 2025 FY 10-K 2026-03-12 0001104659-26-027047
us-gaap ValuationAllowanceDeferredTaxAssetChangeInAmount Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount USD 11.60M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-12 0001104659-26-027047
us-gaap VariableLeaseCost Variable Lease, Cost USD 420,000 2023-01-01 2023-12-31 2023 FY 10-K 2024-03-19 0001558370-24-003567
us-gaap WarrantDownRoundFeatureDecreaseInNetIncomeLossToCommonShareholderAmount WarrantDownRoundFeatureDecreaseInNetIncomeLossToCommonShareholderAmount USD 27.14M 2025-01-01 2025-09-30 2026 Q3 10-Q 2026-11-05 0001104659-26-123317
us-gaap WarrantsAndRightsOutstanding Warrants and Rights Outstanding USD 28.91M 2024-12-31 2025 FY 10-K 2026-03-12 0001104659-26-027047
us-gaap WarrantsNotSettleableInCashFairValueDisclosure Warrants Not Settleable in Cash, Fair Value Disclosure USD 8.93M 2024-09-30 2024 Q3 10-Q 2024-11-12 0001558370-24-015306
us-gaap WeightedAverageNumberOfDilutedSharesOutstanding Weighted Average Number of Shares Outstanding, Diluted shares 91.63M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001104659-26-123317
us-gaap WeightedAverageNumberOfShareOutstandingBasicAndDiluted Weighted Average Number of Shares Outstanding, Basic and Diluted shares 40.27M 2021-01-01 2021-09-30 2021 Q3 10-Q 2021-11-01 0001558370-21-013913
us-gaap WeightedAverageNumberOfSharesCommonStockSubjectToRepurchaseOrCancellation Weighted Average Number of Shares, Common Stock Subject to Repurchase or Cancellation shares 14,725 2019-01-01 2019-12-31 2021 FY 10-K 2022-03-10 0001558370-22-003281
us-gaap WeightedAverageNumberOfSharesIssuedBasic Weighted Average Number of Shares Issued, Basic shares 41.85M 2021-01-01 2021-12-31 2021 FY 10-K 2022-03-10 0001558370-22-003281
us-gaap WeightedAverageNumberOfSharesOutstandingBasic Weighted Average Number of Shares Outstanding, Basic shares 91.63M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001104659-26-123317

Financialist News Desk

Our desk turns official SEC filings into news. Each story is checked against the original filing. About us → · Editorial standards →